Tracleer (Bosentan) is a dual endothelin receptor antagonist used to treat pulmonary artery hypertension (PAH). Tracleer enhances the patient's ability to exercise in addition to reducing the effects of PAH, by helping the heart pump the blood in an efficient manner. Tracleer is only available through a special regimen under a certified pharmacy.
Drug Name: Tracleer
Generic name: Bosentan